| Vascular progenitors generated from tankyrase inhibitor-regulated naïve diabetic human iPSC potentiate efficient revascularization of ischemic retina TS Park, L Zimmerlin, R Evans-Moses, J Thomas, JS Huo, R Kanherkar, ... Nature communications 11 (1), 1195, 2020 | 19 | 2020 |
| Running the full human developmental clock in interspecies chimeras using alternative human stem cells with expanded embryonic potential J Thomas, L Zimmerlin, JS Huo, M Considine, L Cope, ET Zambidis npj Regenerative Medicine 6 (1), 25, 2021 | 9 | 2021 |
| MiR-451a and let-7i-5p loaded extracellular vesicles attenuate heme-induced inflammation in hiPSC-derived endothelial cells JJ Thomas, KO Harp, A Bashi, JL Hood, F Botchway, MD Wilson, ... Frontiers in Immunology 13, 1082414, 2022 | 8 | 2022 |
| CD90-targeted lentiviral vectors for HSC gene therapy K Berckmueller, J Thomas, EA Taha, S Choo, R Madhu, G Kanestrom, ... Molecular Therapy 31 (10), 2901-2913, 2023 | 3 | 2023 |
| Now you see me, now you don’t: New approaches to sparing nonmalignant cells from CAR T cell therapies NE Petty, J Thomas, S Radtke, HP Kiem Med 4 (11), 749-751, 2023 | 1 | 2023 |
| 2019–DEVELOPMENT OF CD90-TARGETED IN VIVO HEMATOPOIETIC STEM CELL GENE THERAPY J Thomas, G Kanestrom, D Pande, M Enstrom, H Mack, C Wolf, M Egan, ... Experimental Hematology 137, 104576, 2024 | | 2024 |
| Proteogenomic Reprogramming to a Functional Human Totipotent Stem Cell State via a PARP-DUX4 Regulatory Axis L Zimmerlin, A Angarita, TS Park, R Evans-Moses, J Thomas, S Yan, ... bioRxiv, 2024.06. 14.598510, 2024 | | 2024 |
| CD90-Targeted Cocal-Pseudotyped Lentivirus As a Robust Platform for Human HSC Gene Therapy J Thomas, K Burkmueller, G Kanestrom, S Radtke, HP Kiem Blood 142, 2254, 2023 | | 2023 |
| Treating black patients as “knowers” JJ Thomas, S Johnson, KB Holden, S Hutchins Journal of the National Medical Association, 2023 | | 2023 |
